R. Bashir

1.6k total citations
25 papers, 1.2k citations indexed

About

R. Bashir is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, R. Bashir has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in R. Bashir's work include Muscle Physiology and Disorders (8 papers), Retinal Development and Disorders (7 papers) and Photoreceptor and optogenetics research (6 papers). R. Bashir is often cited by papers focused on Muscle Physiology and Disorders (8 papers), Retinal Development and Disorders (7 papers) and Photoreceptor and optogenetics research (6 papers). R. Bashir collaborates with scholars based in United Kingdom, Italy and United States. R. Bashir's co-authors include C.F. Inglehearn, Alan C. Bird, Douglas H. Lester, Shoumo Bhattacharya, S. Britton, Sharon Keers, Louise V.B. Anderson, Jessica Moss, Kenneth Davison and I. Mahjneh and has published in prestigious journals such as The American Journal of Human Genetics, Human Molecular Genetics and Developmental Biology.

In The Last Decade

R. Bashir

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Bashir United Kingdom 13 930 478 173 169 137 25 1.2k
Leonor Gouveia Sweden 10 682 0.7× 165 0.3× 118 0.7× 133 0.8× 51 0.4× 16 1.4k
Khayrun Nahar Switzerland 7 621 0.7× 169 0.4× 142 0.8× 136 0.8× 43 0.3× 8 1.4k
Yvette Zarb Switzerland 8 608 0.7× 187 0.4× 131 0.8× 131 0.8× 45 0.3× 10 1.3k
Masumi Takeda Japan 14 782 0.8× 389 0.8× 121 0.7× 79 0.5× 35 0.3× 26 1.3k
Iain Fenton United Kingdom 13 1.3k 1.4× 956 2.0× 104 0.6× 44 0.3× 93 0.7× 17 1.7k
Shuhei Kameya Japan 18 968 1.0× 177 0.4× 135 0.8× 186 1.1× 69 0.5× 56 1.1k
Fumi Urano Japan 12 653 0.7× 417 0.9× 31 0.2× 134 0.8× 43 0.3× 21 1.1k
Mei-Ying Liang China 10 551 0.6× 239 0.5× 109 0.6× 157 0.9× 22 0.2× 17 807
Hideji Hashida Japan 19 672 0.7× 520 1.1× 46 0.3× 76 0.4× 42 0.3× 49 1.2k

Countries citing papers authored by R. Bashir

Since Specialization
Citations

This map shows the geographic impact of R. Bashir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Bashir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Bashir more than expected).

Fields of papers citing papers by R. Bashir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Bashir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Bashir. The network helps show where R. Bashir may publish in the future.

Co-authorship network of co-authors of R. Bashir

This figure shows the co-authorship network connecting the top 25 collaborators of R. Bashir. A scholar is included among the top collaborators of R. Bashir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Bashir. R. Bashir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Defour, Aurélia, J. H. van der Meulen, Raksha R. Bhat, et al.. (2014). Dysferlin regulates cell membrane repair by facilitating injury-triggered acid sphingomyelinase secretion. Cell Death and Disease. 5(6). e1306–e1306. 83 indexed citations
3.
Paula, Flavia, et al.. (2001). Novel dysferlin mutations in Brazilian LGMD2B patients. The American Journal of Human Genetics. 2 indexed citations
4.
Weiler, Tracey, R. Bashir, Louise V.B. Anderson, et al.. (1999). Identical Mutation in Patients with Limb Girdle Muscular Dystrophy Type 2B Or Miyoshi Myopathy Suggests a Role for Modifier Gene(s). Human Molecular Genetics. 8(5). 871–877. 142 indexed citations
5.
Anderson, Louise V.B., Kenneth Davison, Jessica Moss, et al.. (1999). Dysferlin is a Plasma Membrane Protein and is Expressed Early in Human Development. Human Molecular Genetics. 8(5). 855–861. 234 indexed citations
6.
Mahjneh, I., Kate Bushby, L. Anderson, et al.. (1999). Merosin-Positive Congenital Muscular Dystrophy: A Large Inbred Family. Neuropediatrics. 30(1). 22–28. 5 indexed citations
7.
Ebadi, Manuchair, R. Bashir, Margaret L. Heidrick, et al.. (1997). NEUROTROPHINS AND THEIR RECEPTORS IN NERVE INJURY AND REPAIR. Neurochemistry International. 30(4-5). 347–374. 209 indexed citations
8.
Bushby, Kate, R. Bashir, Sharon Keers, et al.. (1996). The molecular biology of LGMD2B — Towards the identification of the LGMD gene on chromosome 2p13. Neuromuscular Disorders. 6(6). 491–492. 3 indexed citations
9.
Mahjneh, I., Maria-Rita Passos-Bueno, Mayana Zatz, et al.. (1996). The phenotype of chromosome 2p-linked limb-girdle muscular dystrophy. Neuromuscular Disorders. 6(6). 483–490. 39 indexed citations
10.
Mahjneh, I., K. Bushby, A. Pizzi, R. Bashir, & Gianpiero Marconi. (1996). Limb-girdle muscular dystrophy: a follow-up study of 79 patients. Acta Neurologica Scandinavica. 94(3). 177–189. 17 indexed citations
11.
Mahjneh, I., K. Bushby, A. Pizzi, R. Bashir, & Gianpiero Marconi. (1996). Limb-girdle muscular dystrophy: A follow-up study of 79 patients. Neuromuscular Disorders. 6(2). S9–S9. 3 indexed citations
12.
Passos‐Bueno, Maria Rita, Eloísa S. Moreira, Suely Kazue Nagahashi Marie, et al.. (1996). Main clinical features of the three mapped autosomal recessive limb-girdle muscular dystrophies and estimated proportion of each form in 13 Brazilian families.. Journal of Medical Genetics. 33(2). 97–102. 38 indexed citations
13.
Bashir, R., C.F. Inglehearn, T J Keen, et al.. (1992). Exclusion of chromosome 6 and 8 locations in nonrhodopsin autosomal dominant retinitis pigmentosa families: Further locus heterogeneity in adRP. Genomics. 14(1). 191–193. 4 indexed citations
14.
Bashir, R., Christopher P. Day, O.F.W. James, et al.. (1992). No evidence for involvement of type 1 collagen structural genes in ‘genetic predisposition’ to alcoholic cirrhosis. Journal of Hepatology. 16(3). 316–319. 8 indexed citations
15.
Inglehearn, Chris F., Douglas H. Lester, R. Bashir, et al.. (1992). Recombination between rhodopsin and locus D3S47 (C17) in rhodopsin retinitis pigmentosa families.. PubMed. 50(3). 590–7. 12 indexed citations
16.
Bashir, R., et al.. (1991). IDENTIFICATION OF NOVEL RHODOPSIN MUTATIONS IN PATIENTS WITH AUTOSOMAL DOMINANT RETINITIS-PIGMENTOSA. UCL Discovery (University College London). 4 indexed citations
17.
Keen, T J, C.F. Inglehearn, Douglas H. Lester, et al.. (1991). Autosomal dominant retinitis pigmentosa: Four new mutations in rhodopsin, one of them in the retinal attachment site. Genomics. 11(1). 199–205. 129 indexed citations
18.
Inglehearn, C.F., M Jay, Douglas H. Lester, et al.. (1990). no evidence for linkage between late onset autosomal dominant retinitis pigmentosa and chromosome 3 locus D3S47 (C17): Evidence for genetic heterogeneity. Genomics. 6(1). 168–173. 28 indexed citations
19.
Farrar, G. Jane, Paul F. Kenna, R M Redmond, et al.. (1990). Autosomal dominant retinitis pigmentosa: absence of the rhodopsin proline->histidine substitution (codon 23) in pedigrees from Europe. PubMed. 47(6). 941–5. 55 indexed citations
20.
Bashir, R. & Fred H. Hochberg. (1988). Paraneoplastic Neurological Syndromes. Cancer Investigation. 6(1). 117–118. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026